 |
|
Percutaneous Absorption of Minoxidil in Man
Thomas J. Franz, MD
Arch Dermatol. 1985;121(2):203-206.
Abstract
• The percutaneous absorption and excretion of 1% and 5% solutions of minoxidil labeled with carbon 14 were measured in 12 adult male subjects. These subjects were randomly assigned to the 1% and 5% minoxidil testing groups, and all received nine topical applications to a bald area on the scalp, with the radioactive solutions applied on days 1 and 9. Urinary excretion of radioactivity was low, with mean values ranging from 1.6% to 3.9% of applied dose. No radioactivity could be detected in fecal samples. Recovery of radioactivity from the skin surface and from scalp and pillowcase washes was in the range of 41% to 45% of applied dose. No adverse reactions or notable abnormalities were noted in the subjects during the study. Although minoxidil is poorly absorbed through the skin, systemic doses in the range of 2.4 to 5.4 mg/day can be anticipated if application is made to entire scalp.
(Arch Dermatol 1985;121:203-206)
Author Affiliations
From the Dermatopharmacology Laboratory, University of Washington School of Medicine, Seattle.
Footnotes
Accepted for publication Aug 3, 1984.
Reprints not available.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Alopecia Areata, Topical Minoxidil, and Balanced Reviews-Reply
Fiedler
Arch Dermatol 1993;129:909-909.
ABSTRACT
Topical Minoxidil: A Survey of Use and Complications
Stern
Arch Dermatol 1987;123:62-65.
ABSTRACT
Topical Minoxidil Dose-Response Effect in Alopecia Areata
Fiedler-Weiss et al.
Arch Dermatol 1986;122:180-182.
ABSTRACT
Percutaneous Absorption of Minoxidil
el-Azhary and Goldberg
Arch Dermatol 1986;122:15-15.
ABSTRACT
Topical Minoxidil Therapy and Hair Regrowth
Weiss and West
Arch Dermatol 1985;121:191-192.
ABSTRACT
|
